2 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 2 of 2 clinical reviews.
Evidence-based guide to safely discontinuing methimazole (Tapazole) for hyperthyroidism and Graves' disease, including taper schedules, lab monitoring, relapse predictors, and when definitive therapy may be preferred.
A full clinical review of methimazole-induced and hyperthyroidism-related hair and skin changes, including alopecia, urticaria, and vasculitis, with primary-literature citations and management guidance.
LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.